CAS Number: 152854-19-8

Stage: Pipeline

Xanomeline Tartrate is a muscarinic receptor agonist with preference for M1/M4 subtypes, under investigation for the treatment of schizophrenia and Alzheimer’s disease-related psychosis. By modulating cholinergic neurotransmission, Xanomeline Tartrate offers a novel mechanism with potential to reduce both positive and negative symptoms of psychiatric disorders. Explore Royal Pharma as your potential partner for Xanomeline Tartrate API.